Upstream Bio, Inc. (UPB) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-3.49x
Upstream Bio, Inc. (UPB) has a Cash Flow-to-Debt Ratio of -3.49x as of June 2026, meaning its operating cash flow of $-35.62 Million could theoretically repay -3% of its total liabilities ($10.21 Million) in one year. See UPB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-3.49x
Operating CF / Total Liabilities
Operating Cash Flow
$-35.62 Million
USD
Total Liabilities
$10.21 Million
USD
Data as of
Jun 2026
Most recent filing
Upstream Bio, Inc. Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Upstream Bio, Inc. across 4 annual periods. For the full cash flow conversion analysis, see Upstream Bio, Inc. operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Upstream Bio, Inc. (2022–2025)
Year-by-year debt coverage analysis for Upstream Bio, Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -9.52x | $-133.28 Million | $14.00 Million | ▼ -90.9% |
| 2024 | -4.99x | $-59.17 Million | $11.87 Million | ▼ -3059.6% |
| 2023 | -0.16x | $-37.93 Million | $240.32 Million | ▼ -3.4% |
| 2022 | -0.15x | $-19.02 Million | $124.63 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.